Hiroshi Mashimo, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 24 | 2023 | 494 | 4.730 |
Why?
|
| Esophagus | 14 | 2020 | 1019 | 2.820 |
Why?
|
| Esophagoscopy | 16 | 2020 | 390 | 2.580 |
Why?
|
| Esophageal Neoplasms | 19 | 2023 | 1583 | 2.370 |
Why?
|
| Tomography, Optical Coherence | 22 | 2020 | 2657 | 2.330 |
Why?
|
| Precancerous Conditions | 8 | 2018 | 975 | 1.840 |
Why?
|
| Esophagogastric Junction | 11 | 2020 | 313 | 1.650 |
Why?
|
| Gastroesophageal Reflux | 9 | 2023 | 782 | 1.620 |
Why?
|
| Adenocarcinoma | 16 | 2023 | 6364 | 1.130 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2015 | 868 | 1.070 |
Why?
|
| Enteric Nervous System | 3 | 2019 | 189 | 1.030 |
Why?
|
| Esophageal Sphincter, Lower | 3 | 2020 | 20 | 0.940 |
Why?
|
| Catheter Ablation | 10 | 2017 | 2758 | 0.940 |
Why?
|
| Radiation Injuries | 3 | 2019 | 1180 | 0.930 |
Why?
|
| Proctitis | 3 | 2014 | 40 | 0.920 |
Why?
|
| Angiography | 4 | 2019 | 1639 | 0.890 |
Why?
|
| Nitric Oxide Synthase | 9 | 2005 | 916 | 0.860 |
Why?
|
| Esophageal Diseases | 2 | 2012 | 166 | 0.780 |
Why?
|
| Gastric Emptying | 3 | 2019 | 233 | 0.760 |
Why?
|
| Stomach Neoplasms | 8 | 2018 | 1333 | 0.710 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2013 | 1222 | 0.660 |
Why?
|
| Rectal Diseases | 1 | 2019 | 143 | 0.610 |
Why?
|
| Microvessels | 2 | 2019 | 544 | 0.600 |
Why?
|
| Proton Pump Inhibitors | 4 | 2020 | 526 | 0.600 |
Why?
|
| Stomach | 4 | 2015 | 697 | 0.520 |
Why?
|
| Oxyphil Cells | 1 | 2015 | 57 | 0.520 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2014 | 4042 | 0.500 |
Why?
|
| Stem Cells | 4 | 2015 | 3567 | 0.500 |
Why?
|
| Ki-67 Antigen | 2 | 2015 | 644 | 0.500 |
Why?
|
| Histamine Antagonists | 1 | 2013 | 93 | 0.450 |
Why?
|
| Fundoplication | 4 | 2020 | 138 | 0.450 |
Why?
|
| Metaplasia | 7 | 2018 | 313 | 0.440 |
Why?
|
| Endoscopy, Digestive System | 2 | 2012 | 345 | 0.430 |
Why?
|
| Choristoma | 1 | 2012 | 213 | 0.360 |
Why?
|
| Microcirculation | 1 | 2014 | 1286 | 0.350 |
Why?
|
| Gastric Mucosa | 2 | 2012 | 599 | 0.340 |
Why?
|
| Gastrointestinal Motility | 5 | 2019 | 225 | 0.320 |
Why?
|
| Radiotherapy | 2 | 2014 | 1533 | 0.320 |
Why?
|
| Mucins | 3 | 2015 | 564 | 0.320 |
Why?
|
| Intestinal Mucosa | 7 | 2009 | 3036 | 0.310 |
Why?
|
| Hirschsprung Disease | 1 | 2009 | 155 | 0.300 |
Why?
|
| Rectum | 2 | 2019 | 904 | 0.300 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 1130 | 0.290 |
Why?
|
| Nitric Oxide Synthase Type I | 8 | 2008 | 170 | 0.290 |
Why?
|
| Endoscopy | 2 | 2015 | 1785 | 0.270 |
Why?
|
| Health | 1 | 2008 | 394 | 0.260 |
Why?
|
| Cardia | 2 | 2018 | 57 | 0.250 |
Why?
|
| Neurotransmitter Agents | 2 | 1999 | 647 | 0.240 |
Why?
|
| Neural Inhibition | 3 | 2007 | 602 | 0.230 |
Why?
|
| Growth Substances | 2 | 1996 | 784 | 0.230 |
Why?
|
| Esophageal Motility Disorders | 1 | 2023 | 44 | 0.220 |
Why?
|
| Neurons | 3 | 2019 | 9338 | 0.220 |
Why?
|
| Nitric Oxide | 5 | 2008 | 2132 | 0.210 |
Why?
|
| Muscle Relaxation | 3 | 2011 | 142 | 0.200 |
Why?
|
| Microscopy, Confocal | 3 | 2020 | 1970 | 0.200 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1294 | 0.200 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2010 | 990 | 0.200 |
Why?
|
| Humans | 61 | 2023 | 744343 | 0.190 |
Why?
|
| Manometry | 3 | 2020 | 445 | 0.190 |
Why?
|
| Muscle Proteins | 2 | 1996 | 1159 | 0.180 |
Why?
|
| Lymphatic Metastasis | 3 | 2018 | 2924 | 0.180 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1620 | 0.180 |
Why?
|
| China | 6 | 2015 | 2248 | 0.180 |
Why?
|
| Neuropeptides | 2 | 1996 | 942 | 0.180 |
Why?
|
| Gastrointestinal Tract | 3 | 2017 | 814 | 0.180 |
Why?
|
| Hernia, Hiatal | 1 | 2020 | 79 | 0.180 |
Why?
|
| Motilin | 1 | 2019 | 3 | 0.170 |
Why?
|
| Heartburn | 1 | 2019 | 68 | 0.170 |
Why?
|
| Proctoscopy | 1 | 2019 | 42 | 0.170 |
Why?
|
| Image Enhancement | 2 | 2007 | 2921 | 0.170 |
Why?
|
| DNA | 1 | 2013 | 7301 | 0.170 |
Why?
|
| Omeprazole | 1 | 2019 | 112 | 0.170 |
Why?
|
| Capsule Endoscopy | 1 | 2020 | 125 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type III | 6 | 2007 | 689 | 0.160 |
Why?
|
| Carcinoma | 3 | 2015 | 2375 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2005 | 534 | 0.160 |
Why?
|
| Immunohistochemistry | 7 | 2015 | 11366 | 0.160 |
Why?
|
| Mucous Membrane | 2 | 2013 | 673 | 0.150 |
Why?
|
| Peptides | 3 | 2008 | 4409 | 0.150 |
Why?
|
| Ghrelin | 1 | 2019 | 266 | 0.150 |
Why?
|
| H-2 Antigens | 4 | 1992 | 366 | 0.140 |
Why?
|
| Gastric Fundus | 1 | 1996 | 39 | 0.140 |
Why?
|
| Keratin-7 | 1 | 2015 | 57 | 0.130 |
Why?
|
| Keratin-5 | 1 | 2015 | 46 | 0.130 |
Why?
|
| Aged | 20 | 2020 | 163280 | 0.130 |
Why?
|
| Male | 34 | 2023 | 350118 | 0.130 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 57776 | 0.130 |
Why?
|
| Colonic Polyps | 1 | 2020 | 542 | 0.130 |
Why?
|
| Muramidase | 1 | 2015 | 174 | 0.130 |
Why?
|
| Epithelium | 3 | 2015 | 1679 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 146 | 0.120 |
Why?
|
| Disease Progression | 6 | 2017 | 13284 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 172 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 3 | 2005 | 4462 | 0.120 |
Why?
|
| Biopsy | 3 | 2020 | 6756 | 0.120 |
Why?
|
| Treatment Outcome | 11 | 2019 | 63114 | 0.120 |
Why?
|
| Synaptic Transmission | 2 | 1999 | 1178 | 0.120 |
Why?
|
| Chronic Disease | 3 | 2019 | 9146 | 0.110 |
Why?
|
| Rotation | 1 | 2014 | 523 | 0.110 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2015 | 494 | 0.110 |
Why?
|
| Middle Aged | 20 | 2020 | 213383 | 0.110 |
Why?
|
| Mice, Knockout | 6 | 2007 | 14557 | 0.110 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 437 | 0.110 |
Why?
|
| Reflex | 2 | 2005 | 365 | 0.100 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2014 | 306 | 0.100 |
Why?
|
| Argon | 1 | 2011 | 36 | 0.100 |
Why?
|
| Veterans | 2 | 2022 | 2519 | 0.100 |
Why?
|
| Duodenum | 2 | 2012 | 483 | 0.100 |
Why?
|
| Gastroenterology | 1 | 2017 | 536 | 0.100 |
Why?
|
| Liposarcoma | 1 | 2014 | 333 | 0.100 |
Why?
|
| Catheters | 1 | 2014 | 425 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11124 | 0.100 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 258 | 0.100 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 11031 | 0.100 |
Why?
|
| Animals | 30 | 2023 | 168757 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2008 | 255 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2008 | 1866 | 0.090 |
Why?
|
| Demography | 1 | 2015 | 1656 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1376 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5078 | 0.090 |
Why?
|
| beta Catenin | 1 | 2015 | 1059 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2013 | 530 | 0.090 |
Why?
|
| Electric Stimulation | 3 | 2008 | 1767 | 0.090 |
Why?
|
| Colon | 3 | 2009 | 1772 | 0.090 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 254 | 0.090 |
Why?
|
| Colitis | 3 | 2004 | 1170 | 0.090 |
Why?
|
| Laser Coagulation | 1 | 2011 | 326 | 0.090 |
Why?
|
| World Health Organization | 1 | 2015 | 1318 | 0.090 |
Why?
|
| Mice | 24 | 2023 | 81183 | 0.080 |
Why?
|
| Duodenogastric Reflux | 1 | 2008 | 5 | 0.080 |
Why?
|
| Life Style | 1 | 2020 | 3835 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1486 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39050 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5172 | 0.080 |
Why?
|
| Pylorus | 1 | 2008 | 86 | 0.080 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2007 | 60 | 0.080 |
Why?
|
| Deglutition | 3 | 2020 | 197 | 0.080 |
Why?
|
| Equipment Design | 3 | 2020 | 3582 | 0.070 |
Why?
|
| Chick Embryo | 1 | 2009 | 982 | 0.070 |
Why?
|
| Watchful Waiting | 1 | 2011 | 492 | 0.070 |
Why?
|
| Cryosurgery | 1 | 2011 | 453 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2009 | 566 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 19905 | 0.070 |
Why?
|
| Gastroparesis | 1 | 2008 | 131 | 0.070 |
Why?
|
| Neuroendocrine Tumors | 1 | 2012 | 594 | 0.070 |
Why?
|
| Glycoproteins | 3 | 2008 | 2263 | 0.070 |
Why?
|
| Female | 22 | 2020 | 380194 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2019 | 8324 | 0.070 |
Why?
|
| Intestine, Large | 1 | 2005 | 71 | 0.070 |
Why?
|
| Gastrectomy | 3 | 2018 | 663 | 0.070 |
Why?
|
| Artifacts | 1 | 2014 | 1904 | 0.070 |
Why?
|
| Neuromuscular Junction | 1 | 2007 | 398 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 4266 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.060 |
Why?
|
| Paris | 2 | 2014 | 42 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 9 | 2008 | 21827 | 0.060 |
Why?
|
| Vagus Nerve | 2 | 2008 | 438 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2009 | 1539 | 0.060 |
Why?
|
| Quality of Life | 3 | 2023 | 12804 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12245 | 0.060 |
Why?
|
| Intestines | 2 | 2008 | 1924 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 1999 | 934 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 1678 | 0.060 |
Why?
|
| Adult | 10 | 2019 | 214055 | 0.060 |
Why?
|
| Microscopy | 1 | 2009 | 903 | 0.060 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 2003 | 16 | 0.060 |
Why?
|
| Gene Targeting | 5 | 1997 | 880 | 0.060 |
Why?
|
| Arginine | 2 | 2005 | 944 | 0.060 |
Why?
|
| Anal Canal | 1 | 2005 | 376 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2023 | 184 | 0.050 |
Why?
|
| Video Recording | 1 | 2007 | 949 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 253 | 0.050 |
Why?
|
| Deoxyribonucleases | 1 | 2023 | 214 | 0.050 |
Why?
|
| Pressure | 1 | 2005 | 1203 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2014 | 8949 | 0.050 |
Why?
|
| Survival Rate | 3 | 2012 | 12788 | 0.050 |
Why?
|
| Esophagoscopes | 1 | 2000 | 18 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14722 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 25043 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2005 | 776 | 0.050 |
Why?
|
| Disease Management | 1 | 2011 | 2459 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6773 | 0.050 |
Why?
|
| Base Sequence | 5 | 1996 | 12797 | 0.050 |
Why?
|
| Esophageal Achalasia | 1 | 2001 | 91 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2005 | 1240 | 0.040 |
Why?
|
| Forecasting | 1 | 2009 | 2951 | 0.040 |
Why?
|
| Tyrosine | 1 | 2004 | 1461 | 0.040 |
Why?
|
| Desipramine | 1 | 2019 | 184 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2009 | 3748 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 1999 | 121 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2023 | 2942 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 2007 | 1137 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2005 | 1241 | 0.040 |
Why?
|
| Muscle Relaxants, Central | 1 | 2019 | 86 | 0.040 |
Why?
|
| Baclofen | 1 | 2019 | 129 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2023 | 695 | 0.040 |
Why?
|
| Tomography | 1 | 2000 | 390 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 2728 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 18111 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 6538 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 12745 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4026 | 0.040 |
Why?
|
| Gastrins | 1 | 1997 | 81 | 0.040 |
Why?
|
| Colonoscopy | 2 | 2020 | 1367 | 0.040 |
Why?
|
| Adenoma | 1 | 2008 | 2174 | 0.040 |
Why?
|
| Vasodilation | 2 | 1999 | 944 | 0.040 |
Why?
|
| Capsule Endoscopes | 1 | 2016 | 16 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3690 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12959 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 2649 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 1997 | 156 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 4034 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 1996 | 236 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2017 | 290 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2020 | 528 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1996 | 179 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2018 | 77449 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12208 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 151 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 1995 | 87 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2023 | 2967 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2023 | 1940 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2005 | 2616 | 0.030 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1996 | 365 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1995 | 642 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1999 | 951 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 574 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2019 | 1609 | 0.030 |
Why?
|
| Fiducial Markers | 1 | 2014 | 136 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 2 | 1987 | 936 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 622 | 0.030 |
Why?
|
| Nervous System | 1 | 1996 | 554 | 0.030 |
Why?
|
| Reference Values | 1 | 2000 | 4982 | 0.030 |
Why?
|
| Genes | 2 | 1995 | 1893 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17446 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5179 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 970 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 1995 | 13815 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2014 | 468 | 0.030 |
Why?
|
| Age Factors | 1 | 2009 | 18370 | 0.030 |
Why?
|
| Body Patterning | 1 | 1996 | 626 | 0.030 |
Why?
|
| Antigens, Surface | 3 | 1990 | 1663 | 0.030 |
Why?
|
| Esophagitis | 1 | 2013 | 152 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2011 | 81 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 1995 | 3768 | 0.020 |
Why?
|
| Risk Factors | 4 | 2018 | 72290 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1995 | 2327 | 0.020 |
Why?
|
| Esophagectomy | 1 | 2014 | 447 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2839 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2256 | 0.020 |
Why?
|
| Gene Expression | 2 | 1995 | 7799 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 2025 | 0.020 |
Why?
|
| Leukemia, T-Cell | 1 | 1989 | 104 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2013 | 382 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 2013 | 386 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 12354 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6489 | 0.020 |
Why?
|
| Mass Screening | 1 | 2005 | 5255 | 0.020 |
Why?
|
| Mental Health | 1 | 2022 | 3019 | 0.020 |
Why?
|
| Apamin | 1 | 2007 | 23 | 0.020 |
Why?
|
| Bezoars | 1 | 2008 | 30 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2902 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 40075 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1996 | 1774 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 1989 | 376 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7279 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13408 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 1992 | 6386 | 0.020 |
Why?
|
| Bile | 1 | 2008 | 299 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2214 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5720 | 0.020 |
Why?
|
| Axons | 1 | 1995 | 1684 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6622 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 16689 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1996 | 2575 | 0.020 |
Why?
|
| Phenotype | 4 | 2011 | 16365 | 0.020 |
Why?
|
| Transfection | 2 | 1990 | 5892 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 1308 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15076 | 0.020 |
Why?
|
| Bacterial Translocation | 1 | 2004 | 73 | 0.020 |
Why?
|
| Cell Movement | 1 | 1996 | 5217 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1989 | 1758 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2004 | 226 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3616 | 0.010 |
Why?
|
| Retina | 1 | 1995 | 2616 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 4776 | 0.010 |
Why?
|
| Ganglia, Parasympathetic | 1 | 2003 | 19 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.010 |
Why?
|
| Peristalsis | 1 | 2003 | 60 | 0.010 |
Why?
|
| Heart | 1 | 1996 | 4467 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1995 | 4456 | 0.010 |
Why?
|
| Efferent Pathways | 1 | 2003 | 167 | 0.010 |
Why?
|
| Homozygote | 2 | 1997 | 1785 | 0.010 |
Why?
|
| Goblet Cells | 1 | 2004 | 287 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2645 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4234 | 0.010 |
Why?
|
| Peroxidase | 1 | 2004 | 611 | 0.010 |
Why?
|
| Kidney | 1 | 1996 | 7186 | 0.010 |
Why?
|
| Sex Factors | 1 | 2014 | 10397 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7729 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1995 | 13033 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1588 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1995 | 8554 | 0.010 |
Why?
|
| Inflammation | 1 | 1999 | 10638 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1986 | 1366 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 1726 | 0.010 |
Why?
|
| Parietal Cells, Gastric | 1 | 1997 | 47 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2003 | 844 | 0.010 |
Why?
|
| Mutation | 4 | 1996 | 29786 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8663 | 0.010 |
Why?
|
| Gastric Acid | 1 | 1997 | 104 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3798 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1997 | 322 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1989 | 3703 | 0.010 |
Why?
|
| Semaphorin-3A | 1 | 1996 | 39 | 0.010 |
Why?
|
| Diet | 1 | 2015 | 7939 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1997 | 399 | 0.010 |
Why?
|
| Carbachol | 1 | 1997 | 226 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1997 | 174 | 0.010 |
Why?
|
| Atropine | 1 | 1997 | 244 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2009 | 1912 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 803 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4751 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 878 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1981 | 1381 | 0.010 |
Why?
|
| Leukocytes | 1 | 2004 | 2043 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 1997 | 240 | 0.010 |
Why?
|
| Hypertension | 1 | 1995 | 8480 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 7913 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15226 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 1995 | 152 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 13989 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1997 | 621 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1996 | 346 | 0.010 |
Why?
|
| Nervous System Malformations | 1 | 1996 | 247 | 0.010 |
Why?
|
| Urine | 1 | 1996 | 370 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1997 | 964 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1990 | 4320 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 13881 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 2749 | 0.010 |
Why?
|
| Optic Nerve | 1 | 1997 | 554 | 0.010 |
Why?
|
| Chimera | 1 | 1995 | 485 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1995 | 249 | 0.010 |
Why?
|
| Cell Line | 3 | 1996 | 15997 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5974 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 1583 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1995 | 519 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 23338 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1997 | 19229 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1995 | 1586 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 29063 | 0.010 |
Why?
|
| Heterozygote | 1 | 1996 | 2804 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 4568 | 0.010 |
Why?
|
| Retinal Ganglion Cells | 1 | 1995 | 770 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1989 | 829 | 0.010 |
Why?
|
| Fetus | 1 | 1996 | 1880 | 0.010 |
Why?
|
| Aorta | 1 | 1995 | 2061 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1986 | 248 | 0.000 |
Why?
|
| Protein Conformation | 2 | 1987 | 4011 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1990 | 1369 | 0.000 |
Why?
|
| Gene Expression Regulation | 2 | 1997 | 12072 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 1085 | 0.000 |
Why?
|
| Homeostasis | 1 | 1995 | 3340 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 9734 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1981 | 10180 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1997 | 6442 | 0.000 |
Why?
|
| Signal Transduction | 2 | 1997 | 23403 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1990 | 1821 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1989 | 3870 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1987 | 1276 | 0.000 |
Why?
|
| beta 2-Microglobulin | 1 | 1981 | 315 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1981 | 517 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1990 | 4161 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1981 | 2255 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1987 | 1988 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 1454 | 0.000 |
Why?
|
| Clone Cells | 1 | 1981 | 1692 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11483 | 0.000 |
Why?
|
| Alleles | 1 | 1986 | 6933 | 0.000 |
Why?
|
| Epitopes | 1 | 1981 | 2571 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1987 | 6544 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1987 | 9274 | 0.000 |
Why?
|